Skip to content
Search

Latest Stories

Drugs official flayed for inaction against Baba Ramdev firm

The Supreme Court bench said the drugs authority had failed to act after issuing a warning to Divya Pharmacy over the advertisements

Drugs official flayed for inaction against Baba Ramdev firm

India's Supreme Court has admonished the head of a state drugs regulator for failing to take action against a popular yoga guru Baba Ramdev's firm which claimed its traditional ayurvedic medicines can cure diseases such as diabetes and asthma.

The top court said on Wednesday the state drugs department had "tried to pass on the buck" despite being informed in 2018 of advertisements issued by Divya Pharmacy, a unit of yoga guru's hugely popular firm Patanjali Ayurved.


Ramdev, dressed in a saffron-coloured robe, attended the hearing of a contempt case against Patanjali for defying court directives to stop publishing the ads.

Mithilesh Kumar, the head of Uttarakhand state drugs regulator, also attended the session. With folded hands, he pleaded with the judges to give him more time to take action against the company, which the judges refused.

"Why should we not come down on your officers like a ton of bricks?" Justice Hima Kohli asked the Uttarakhand state counsel.

"Instead of taking action, the state licensing authority told (the federal government) that it has issued a warning to the concerned firm and further action will be subject to the direction of the Supreme Court," Kohli said.

Ramdev is one of India's top yoga gurus and offers ayurvedic cures for many illnesses through his TV shows. He has also shared the stage with ministers in Prime Minister Narendra Modi's government and leaders of the ruling Bharatiya Janata Party in the past.

The two-judge bench said the drugs authority remained in "deep slumber" on the issue and had failed to act after issuing a warning to the firm over the advertisements.

The bench also refused to accept a second apology by Ramdev and Patanjali co-founder Acharya Balkrishna for defying the court's order. It set April 16 as the next date for the hearing. (Reuters)

More For You

H1B programme

Brat has claimed that Chennai issued 220,000 H-1B visas despite the US cap of 85,000.

iStock

Economist alleges H-1B fraud as Chennai shows 220,000 approvals against US cap

AMERICA's H-1B visa system has come under renewed scrutiny after US economist and former Representative Dave Brat claimed that visa approvals had exceeded statutory limits.

Brat said on Steve Bannon’s War Room podcast that although the annual cap is 85,000, Chennai alone accounted for 220,000 H-1B approvals.

Keep ReadingShow less